|
|
||||||||
Ann Thorac Surg 2001;72:1149-1154
© 2001 The Society of Thoracic Surgeons
a Thoracic Service, Department of Surgery, New York, New York, USA
b Thoracic Oncology Service, Department of Medicine, New York, New York, USA
c Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Address reprint requests to Dr Rusch, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021
e-mail: ruschv{at}mskcc.org
Presented at the Poster Session of the Thirty-seventh Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 2931, 2001.
Background. The risks of complications in patients undergoing thoracotomy after neoadjuvant therapy for nonsmall cell lung cancer remain controversial. We reviewed our experience to define it further.
Methods. All patients undergoing thoracotomy after induction chemotherapy from 1993 through 1999 were reviewed. Univariate and multivariate methods for logistic regression model were used to identify predictors of adverse events.
Results. Induction chemotherapy included mitomycin, vinblastine, and cisplatin (179 patients), carboplatin and paclitaxel (152 patients), and other combinations (139 patients). Eighty-five patients (18%) received preoperative radiation. Operations were pneumonectomy (97 patients), lobectomy (297 patients), lesser resection (18 patients), and exploration only (58 patients). Total mortality was 7 of 297 (2.4%) and 11 of 97 (11.3%) for all lobectomies and pneumonectomies, respectively, but mortality was 11 of 46 (23.9%) for right pneumonectomy. Complications developed in 179 patients (38%). By multiple regression analysis, right pneumonectomy (p = 0.02), blood loss (p = 0.01), and forced expiratory volume in one second (percent predicted) (p = 0.01) predicted complications. No factor emerged to explain this high right pneumonectomy mortality rate.
Conclusions. Pulmonary resection after neoadjuvant therapy is associated with acceptable overall morbidity and mortality. However, right pneumonectomy is associated with a significantly increased risk and should be performed only in selected patients.
Related Article
Ann. Thorac. Surg. 2001 72: 1154.
This article has been cited by other articles:
![]() |
B. Yildizeli, P. G. Dartevelle, E. Fadel, S. Mussot, and A. Chapelier Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk. Ann. Thorac. Surg., October 1, 2008; 86(4): 1065 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gudbjartsson, E. Gyllstedt, A. Pikwer, and P. Jonsson Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy. Ann. Thorac. Surg., August 1, 2008; 86(2): 376 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mansour, E. A. Kochetkova, N. Santelmo, X. Ducrocq, E. Quoix, J.-M. Wihlm, and G. Massard Persistent n2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy. Ann. Thorac. Surg., July 1, 2008; 86(1): 228 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alifano, M. S. Boudaya, M. Salvi, J.-Y. Collet, C. Dinu, S. Camilleri-Broet, and J.-F. Regnard Pneumonectomy after chemotherapy: morbidity, mortality, and long-term outcome. Ann. Thorac. Surg., June 1, 2008; 85(6): 1866 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Kesler, Z. T. Hammoud, K. M. Rieger, L. E. Kruter, M. Yu, and J. W. Brown Carinaplasty Airway Closure: A Technique for Right Pneumonectomy Ann. Thorac. Surg., April 1, 2008; 85(4): 1178 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, K. McRae, M. Anraku, K. Karkouti, T. K. Waddell, A. F. Pierre, G. Darling, S. Keshavjee, and M. R. Johnston Risk Factors for Major Complications After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma Ann. Thorac. Surg., April 1, 2008; 85(4): 1206 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Darling Reply to the Editor J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 718 - 719. [Full Text] [PDF] |
||||
![]() |
A. Borri, F. Leo, G. Veronesi, P. Solli, D. Galetta, R. Gasparri, F. Petrella, P. Scanagatta, D. Radice, and L. Spaggiari Extended pneumonectomy for non-small cell lung cancer: morbidity, mortality, and long-term results. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1266 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Amar, H. Zhang, B. Park, P. M. Heerdt, M. Fleisher, and H. T. Thaler Inflammation and outcome after general thoracic surgery Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 431 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Uy, G. Darling, W. Xu, Q.-L. Yi, M. De Perrot, A. F. Pierre, T. K. Waddell, M. R. Johnston, A. Bezjak, F. A. Shepherd, et al. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 188 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Johnson, V. W. Rusch, and A. T. Turrisi Scalpels, Beams, Drugs, and Dreams: Challenges of Stage IIIA-N2 Non-Small-Cell Lung Cancer J Natl Cancer Inst, March 21, 2007; 99(6): 415 - 418. [Full Text] [PDF] |
||||
![]() |
J. P. van Meerbeeck, G. W. P. M. Kramer, P. E. Y. Van Schil, C. Legrand, E. F. Smit, F. Schramel, V. C. Tjan-Heijnen, B. Biesma, C. Debruyne, N. van Zandwijk, et al. Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer J Natl Cancer Inst, March 21, 2007; 99(6): 442 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pompeo, F. Tacconi, and T. C. Mineo Flexible Videopericardioscopy in cT4 Nonsmall-Cell Lung Cancer With Radiologic Evidence of Proximal Vascular Invasion Ann. Thorac. Surg., February 1, 2007; 83(2): 402 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mansour, E. A. Kochetkova, X. Ducrocq, M.-D. Vasilescu, G. Maxant, A. Buggenhout, J.-M. Wihlm, and G. Massard Induction chemotherapy does not increase the operative risk of pneumonectomy! Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 181 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Leo, P. Solli, G. Veronesi, D. Radice, A. Floridi, R. Gasparri, F. Petrella, A. Borri, D. Galetta, and L. Spaggiari Does chemotherapy increase the risk of respiratory complications after pneumonectomy? J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 519 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D.T. Daly, H. C. Fernando, A. Ketchedjian, T. A. DiPetrillo, L. A. Kachnic, D. M. Morelli, and R. J. Shemin Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. Ann. Thorac. Surg., July 1, 2006; 82(1): 227 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Takeda, Y. Funakoshi, Y. Kadota, M. Koma, H. Maeda, S. Kawamura, and Y. Matsubara Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication? Ann. Thorac. Surg., July 1, 2006; 82(1): 232 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dulu, S. M. Pastores, B. Park, E. Riedel, V. Rusch, and N. A. Halpern Prevalence and Mortality of Acute Lung Injury and ARDS After Lung Resection. Chest, July 1, 2006; 130(1): 73 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Takeda, H. Maeda, T. Okada, T. Yamaguchi, M. Nakagawa, S. Yokota, N. Sawabata, and M. Ohta Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 184 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fujita, N. Katakami, Y. Takahashi, K. Hirokawa, A. Ikeda, C. Tabata, T. Mio, and M. Mishima Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer. Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 896 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brunelli, F. Xiume', M. Al Refai, M. Salati, R. Marasco, and A. Sabbatini Gemcitabine-Cisplatin Chemotherapy Before Lung Resection: A Case-Matched Analysis of Early Outcome Ann. Thorac. Surg., June 1, 2006; 81(6): 1963 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Battafarano Optimal management of patients with non-small cell lung cancer with ipsilateral mediastinal lymph node metastases J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1227 - 1228. [Full Text] [PDF] |
||||
![]() |
O. Schussler, M. Alifano, H. Dermine, S. Strano, A. Casetta, S. Sepulveda, A. Chafik, S. Coignard, A. Rabbat, and J.-F. Regnard Postoperative Pneumonia after Major Lung Resection Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1161 - 1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dancewicz, J. Kowalewski, and J. Peplinski Factors associated with perioperative complications after pneumonectomy for primary carcinoma of the lung Interactive CardioVascular and Thoracic Surgery, April 1, 2006; 5(2): 97 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sugimura and P. Yang Long-term Survivorship in Lung Cancer: A Review. Chest, April 1, 2006; 129(4): 1088 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Bernstein, S. M. Herbert, and N. H. Hanna Chemotherapy and Radiotherapy in the Treatment of Resectable Non-Small-Cell Lung Cancer Ann. Surg. Oncol., March 1, 2006; 13(3): 291 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, E. Fadel, O. Mercier, S. Mussot, A. Chapelier, and P. Dartevelle Long-term results after carinal resection for carcinoma: Does the benefit warrant the risk? J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 81 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Martin, A. M. Correa, W. Hofstetter, W. K. Hong, R. Komaki, J. B. Putnam Jr, D. C. Rice, W. R. Smythe, S. G. Swisher, A. A. Vaporciyan, et al. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1601 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barlesi, L. Boyer, C. Doddoli, S. Antoniotti, P. Thomas, and P. Auquier The Place of Patient Satisfaction in Quality Assessment of Lung Cancer Thoracic Surgery Chest, November 1, 2005; 128(5): 3475 - 3481. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsubara, S.-i. Takeda, and T. Mashimo Risk Stratification for Lung Cancer Surgery: Impact of Induction Therapy and Extended Resection Chest, November 1, 2005; 128(5): 3519 - 3525. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barlesi, C. Doddoli, J.-P. Torre, R. Giudicelli, P. Fuentes, P. Thomas, and P. Astoul Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 629 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Van Schil, J. Van Meerbeeck, G. Kramer, T. Splinter, C. Legrand, G. Giaccone, C. Manegold, and N. van Zandwijk Morbidity and mortality in the surgery arm of EORTC 08941 trial Eur. Respir. J., August 1, 2005; 26(2): 192 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Burfeind Jr, T. A. D'Amico, E. M. Toloza, W. G. Wolfe, and D. H. Harpole Low Morbidity and Mortality for Bronchoplastic Procedures With and Without Induction Therapy Ann. Thorac. Surg., August 1, 2005; 80(2): 418 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Perrot, B. Guibert, P. Mulsant, S. Blandin, I. Arnaud, P. Roy, L. Geriniere, and P.-J. Souquet Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection Ann. Thorac. Surg., August 1, 2005; 80(2): 423 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Doddoli, F. Barlesi, D. Trousse, S. Robitail, S. Yena, P. Astoul, R. Giudicelli, P. Fuentes, and P. Thomas One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: An uncertain balance between risks and benefits J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 416 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pezzetta, R. Stupp, A. Zouhair, L. Guillou, P. Taffe, C. von Briel, T. Krueger, and H.-B. Ris Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1092 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Port, R. J. Korst, P. C. Lee, M. A. Levin, D. E. Becker, R. Keresztes, and N. K. Altorki Surgical Resection for Residual N2 Disease After Induction Chemotherapy Ann. Thorac. Surg., May 1, 2005; 79(5): 1686 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Patel and J. B. Shrager Which Patients with Stage III Non-Small Cell Lung Cancer Should Undergo Surgical Resection? Oncologist, May 1, 2005; 10(5): 335 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Stewart, A. E. Martin-Ucar, J. G. Edwards, K. West, and D. A. Waller Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 373 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Darling, A. Abdurahman, Q.-L. Yi, M. Johnston, T. K. Waddell, A. Pierre, S. Keshavjee, and R. Ginsberg Risk of a Right Pneumonectomy: Role of Bronchopleural Fistula Ann. Thorac. Surg., February 1, 2005; 79(2): 433 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Grichnik and T. A. D'Amico Acute Lung Injury and Acute Respiratory Distress Syndrome After Pulmonary Resection Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 317 - 334. [Abstract] [PDF] |
||||
![]() |
R. S. Andrade, K. A. Kesler, J. L. Wilson, J. A. Brooks, B. D. Reichwage, K. M. Rieger, L. H. Einhorn, and J. W. Brown Short- and Long-Term Outcomes after Large Pulmonary Resection for Germ Cell Tumors After Bleomycin-Combination Chemotherapy Ann. Thorac. Surg., October 1, 2004; 78(4): 1224 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. D'Angelillo, L. Trodella, and S. Ramella Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer. J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 489 - 490. [Full Text] [PDF] |
||||
![]() |
W. Eberhardt, M. Stuschke, and G. Stamatis Preoperative chemoradiation approaches to locally advanced non-small-cell lung cancer: one man's pride, another man's burden? Ann. Onc., March 1, 2004; 15(3): 365 - 367. [Full Text] [PDF] |
||||
![]() |
L. Trodella, P. Granone, S. Valente, S. Margaritora, G. Macis, A. Cesario, R. M. D'Angelillo, V. Valentini, G. M. Corbo, V. Porziella, et al. Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging Ann. Onc., March 1, 2004; 15(3): 389 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Leo, P. Solli, L. Spaggiari, G. Veronesi, F. de Braud, M. E. Leon, and U. Pastorino Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications? Ann. Thorac. Surg., January 1, 2004; 77(1): 260 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Veronesi, M. E. Leon, and L. Spaggiari Safety of bronchoplastic resection after induction therapy for lung cancer J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1670 - 1671. [Full Text] [PDF] |
||||
![]() |
D. C. Betticher, S.-F. Hsu Schmitz, M. Totsch, E. Hansen, C. Joss, C. von Briel, R. A. Schmid, M. Pless, J. Habicht, A. D. Roth, et al. Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non-Small-Cell Lung Cancer: A Multicenter Phase II Trial J. Clin. Oncol., May 1, 2003; 21(9): 1752 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Fuentes Pneumonectomy: historical perspective and prospective insight Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 439 - 445. [Full Text] [PDF] |
||||
![]() |
D. L. Miller, C. Deschamps, G. D. Jenkins, A. Bernard, M. S. Allen, and P. C. Pairolero Completion pneumonectomy: factors affecting operative mortality and cardiopulmonary morbidity Ann. Thorac. Surg., September 1, 2002; 74(3): 876 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martin, R. J. Ginsberg, E. S. Venkatraman, M. S. Bains, R. J. Downey, R. J. Korst, M. G. Kris, and V. W. Rusch Long-Term Results of Combined-Modality Therapy in Resectable Non-Small-Cell Lung Cancer J. Clin. Oncol., April 15, 2002; 20(8): 1989 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Vaporciyan, K. W. Merriman, F. Ece, J. A. Roth, W. R. Smythe, S. G. Swisher, G. L. Walsh, J. C. Nesbitt, and J. B. Putnam Jr Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation Ann. Thorac. Surg., February 1, 2002; 73(2): 420 - 426. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |